Merck KGaA (MKGAF) News Today $135.25 -6.66 (-4.69%) As of 10/9/2025 02:31 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock MKGAF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Trump seeks more drug pricing deals similar to Pfizer’sOctober 1, 2025 | msn.comPfizer – U.S. drug pricing deal boosts EU drugmakersOctober 1, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Shares Gap Up - Time to Buy?October 1, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Sees Large Volume Increase - Should You Buy?September 29, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Stock Price Passes Below Fifty Day Moving Average - Time to Sell?September 26, 2025 | marketbeat.comHHS sends proposed drug pricing rule to White House for reviewSeptember 25, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Shares Gap Down - Here's WhySeptember 25, 2025 | marketbeat.comChinese police investigating app fraud case, says German drugmaker Merck KGaASeptember 23, 2025 | reuters.comMerck KGaA (OTCMKTS:MKGAF) Shares Down 3.5% - Here's What HappenedSeptember 18, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Stock Crosses Below Fifty Day Moving Average - Here's What HappenedSeptember 18, 2025 | marketbeat.comShort Interest in Merck KGaA (OTCMKTS:MKGAF) Expands By 25.3%September 18, 2025 | marketbeat.comIs This the Right Moment to Revisit Merck KGaA After Its Sharp 35% Slide?September 13, 2025 | finance.yahoo.comTrump is said to force Big Pharma to lower drug prices within weeksSeptember 12, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Short Interest Down 24.4% in AugustSeptember 10, 2025 | marketbeat.comBiocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery SolutionsSeptember 3, 2025 | businesswire.comMerck KGaA (OTCMKTS:MKGAF) Stock Price Crosses Below 50 Day Moving Average - Time to Sell?August 21, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Shares Down 5.3% - Time to Sell?August 20, 2025 | marketbeat.comSkyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological DisordersAugust 19, 2025 | finance.yahoo.comMerck announces EC approval of Ogsiveo for desmoid tumoursAugust 19, 2025 | finance.yahoo.comMerck KGaA's (ETR:MRK) Earnings Seem To Be PromisingAugust 14, 2025 | finance.yahoo.comMerck KGaA Second Quarter 2025 Earnings: Misses ExpectationsAugust 11, 2025 | finance.yahoo.comDeutsche Bank lowers Merck KGaA price target to EUR133 on mixed Q2August 11, 2025 | investing.comMerck KGaA (OTCMKTS:MKGAF) Sees Strong Trading Volume - Should You Buy?August 8, 2025 | marketbeat.comMerck KGaA (MKGAF) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst ChallengesAugust 8, 2025 | gurufocus.comMerck KGaA (MKGAF) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comMerck KGaA (MKGAF) Adjusts Full-Year Guidance Amid Q2 ResultsAugust 7, 2025 | gurufocus.comMerck KGaA is looking into direct distribution to U.S. patientsAugust 7, 2025 | reuters.comMerck Mounts $3 Billion Revamp as Keytruda Price Pressure LoomsJuly 29, 2025 | bloomberg.comMerck KGaA (OTCMKTS:MKGAF) Stock Price Passes Above 50 Day Moving Average - Here's What HappenedJuly 25, 2025 | marketbeat.comMerck KGaA: The Undervaluation Is Now Close To 13-Year LowsJuly 25, 2025 | seekingalpha.comMerck KGaA (MKKGY) Upgraded to Strong Buy: Here's WhyJuly 24, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Sees Large Volume Increase - Here's What HappenedJuly 21, 2025 | marketbeat.comMerck KGaA gets EU nod for genetic disorder therapyJuly 18, 2025 | seekingalpha.comMerck KGaA (OTCMKTS:MKGAF) Shares Gap Up - Here's WhyJuly 15, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Shares Gap Down - What's Next?July 14, 2025 | marketbeat.comMerck spends $10 billion for Verona, gaining access to its COPD medicationJuly 9, 2025 | msn.comMerck KGaA (OTCMKTS:MKGAF) Shares Gap Up - Should You Buy?July 8, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Stock Passes Above Fifty Day Moving Average - What's Next?July 5, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Trading Down 3.9% - What's Next?July 3, 2025 | marketbeat.comMerck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare BusinessJuly 1, 2025 | businesswire.comMerck KGaA (OTCMKTS:MKGAF) Trading Down 3.2% - What's Next?June 18, 2025 | marketbeat.comMerck KGaA (OTCMKTS:MKGAF) Stock Price Crosses Above Fifty Day Moving Average - Time to Sell?June 11, 2025 | marketbeat.comChina's Center for Drug Evaluation Accepts Merck's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell TumorJune 9, 2025 | businesswire.comChina's Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany's Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell TumorJune 9, 2025 | businesswire.comMerck KGaA (MKGAF) Files for Global Approval of Pimicotinib After Positive Phase III TGCT ResultsMay 29, 2025 | msn.comMerck KGaA (ETR:MRK) Is Posting Promising Earnings But The Good News Doesn’t Stop ThereMay 22, 2025 | finance.yahoo.comMerck KGaA First Quarter 2025 Earnings: EPS Misses ExpectationsMay 16, 2025 | finance.yahoo.comMerck KGaA (MKGAF) Q1 2025 Earnings Call Highlights: Strong Growth Amidst ChallengesMay 16, 2025 | finance.yahoo.comMerck KGaA Shares Slide After Outlook Cut on Tariff, Currency RisksMay 15, 2025 | msn.comMerck KGaA (MKGAF) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKGAF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MKGAF Media Mentions By Week MKGAF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MKGAF News Sentiment▼0.670.77▲Average Medical News Sentiment MKGAF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MKGAF Articles This Week▼02▲MKGAF Articles Average Week Get the Latest News and Ratings for MKGAF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Merck KGaA and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies UCB News Jyong Biotech News MorphoSys News Zymeworks News Evotec News Silverback Therapeutics News Aerovate Therapeutics News Mawson Infrastructure Group News BioAge Labs News Neoleukin Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MKGAF) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
